Barriers Inhibiting Optimal Pediatric RSV Treatment
Medical experts discuss current obstacles facing ideal respiratory syncytial virus (RSV) treatment strategies in children.
Overview of RSV in Infants and Children
Adam Welch, PharmD, MBA, FAPhA, leads a discussion surrounding payer considerations for RSV vaccinations in children.
Acne Influencing Mental Health Amid Acne Diagnosis
A look at the psychological implications of acne in teenagers and adults.
Acne-Associated Economic Burden
Discussion on the economic burden of over-counter and prescription drug costs related to acne therapy.
Impact of Microsatellite Stability in Metastatic Colorectal Cancer
Dr Marshall describes the impacts of microsatellite stability and instability on metastatic colorectal cancer.
Selecting Appropriate Schizophrenia Treatment
Dr Carney drives a discussion surrounding optimal treatment strategies for schizophrenia.
Current Standards of Care in Schizophrenia
Panelists provide insight into the standards of care for treating patients diagnosed with schizophrenia.
Future Opportunities With Interchangeable Biosimilars
A panel of experts discuss future opportunities with interchangeable biosimilars from payer and provider perspectives.
Interchangeable Biosimilar Automatic Substitution
Jonathan Kay, MD, and Kimberly C. Chen, DO, MSHLM, discuss clinical and financial concerns related to automatic substitution at the pharmacy for an interchangeable biosimilar from a payer perspective.
4 Factors of Acne Pathogenesis
Conversation on the four classic causes of acne as well as pathogenesis.
Current Guidelines and Unmet Needs Impacting Patients with Acne
Introduction of expert panelists and treatment guidelines for patients with acne.
Maximizing Patient Quality of Life through Shared Decision Making in Metastatic Colorectal Cancer
Discussion on shared decision making with patients with later stage refractory metastatic colorectal cancer as well as maximizing a patient's quality of life.
Challenges of Biosimilars With Interchangeable Designations
Maia Kayal, MD, MS, and Kimberly C. Chen, DO, MSHLM, discuss challenges for biosimilars with interchangeable designation related to automatic substitution in the pharmacy.
Cost and Time Benefits of Interchangeable Biosimilars
Kimberly C. Chen, DO, MSHLM, discusses the potential benefits of interchangeable biosimilars to patients and payers.
Health-Related Quality of Life Outcomes in Metastatic Colorectal Cancer: Takeaways from the SUNLIGHT Study
John L. Marshall M.D., shares insights on health-related quality of life (HRQoL) findings from SUNLIGHT study presented at ESMO World Congress on Gastrointestinal Cancer (ESMO GI) 2023.
Assessing Cognitive Function in Patients with Schizophrenia
A panel of medical experts discuss the clinical and financial considerations surrounding the treatment of patients diagnosed with schizophrenia.
Social Determinants of Health Limiting Optimal Treatment for Schizophrenia
Social determinants of health impacting the treatment landscape for schizophrenia are discussed.
Patient and Provider Education on Biosimilars
A panel of experts reviews the emerging interchangeable biosimilars and best practices on how to educate providers and patients on these treatment options.
Interchangeability In Biosimilars
Maia Kayal, MD, MS, and Jonathan Kay, MD, define interchangeability and review the details of a switching study.
Examining Cognitive Impairment Associated with Schizophrenia
Carlos Larrauri, APRN, details the signs and symptoms necessary to make a schizophrenia diagnosis.
Schizophrenia Disease State Overview
John J. Miller, MD, and Nev Jones, PhD, open a discussion providing an overview on the current state of patients with schizophrenia.
Patient-Centered Focus Driving
With their final thoughts, the panelists emphasize patient-centered care is at the forefront of critical MS treatment considerations for providers.
Overall Treatment Objectives for Patients with MS
A comprehensive look into MS treatment objectives is provided.
Key Takeaways Surrounding the Treatment of HIV
Panelists provide their closing thoughts on optimizing the management of HIV.
Trajectory of the HIV Treatment Landscape
The panel of experts discusses emerging and anticipated changes to the HIV treatment landscape.
Updates in MS Clinical Trials
A discussion surrounding clinical trials in multiple sclerosis is led by Dr Haumschild.
Utilizing BTK Inhibitors to Address Unmet Needs in MS
The panel expands on the role of BTK inhibitors in the MS treatment landscape.
Unmet Needs in the Treatment of HIV
The panel discusses unmet needs that remain in the treatment and management of HIV.
Collaborative Care Driving Optimal Care for Patients Diagnosed with HIV
Dr Welch leads a discussion on collaborations between payers, patients, and providers to optimize the care of patients with HIV.
Key Takeaways for Immunizing against RSV
In their closing thoughts, the panelists provide their key takeaways regarding immunizing against RSV.
